Mr. Posard brings over 30 years experience of general management and commercialization experience in the diagnostics, life sciences and pharmaceutical industry.   Matt’s expertise is introducing novel and transformational products to clinical and research markets while scaling organizations rapidly and efficiently.    Matt has held executive title responsibilities with several highly successful growth companies including Illumina, Biosite and Gen-Probe.    From 2006 to 2015, Matt held executive positions at Illumina as its VP of Marketing, VP Global Sales and then as Senior VP, General Manager of its Translational and Consumer Genomics and New and Emerging Markets business units.   Matt currently serves on multiple boards including Halozyme Therapeutics (NASDAQ: HALO), Dermtech, Talis Biomedical, Ignite Bio, Fabric Genomics and Stemson Therapeutics.   Matt holds a Bachelors degree in Management Science from UC San Diego.